European Cohorts of Patients and Schools to Advance Response to Epidemics
HORIZON.2.1HORIZON-RIAID: 101046016
EC Contribution
€99,959
Consortium Size
20 orgs
▶Summary
The EuCARE project gathers a comprehensive multidisciplinary team of clinicians, virologists, epidemiologists, statisticians and top experts in artificial intelligence to unveil the impact of SARS-CoV-2 variants on key sectors of public health, as addressed by the call. The specific activities include:1.The assessment of natural and artificial immunity to the different viral variants in health care workers with the aim of defining the cross-immunization patterns and the risk of vaccine escape, informing vaccination strategies for the general population; 2.The analysis of the clinical course and long-term follow-up of hospitalized COVID-19 patients to derive the role of different viral variants in the outcome of the infection, including post-acute sequelae of SARS-CoV-2 infection; 3.The definition of the best strategies to control the spread of different viral variants in schools, by comparing the outcome of diverse containment and prevention measures in relation to the prevalence and dynamics of the variants. To ensure a suitable representativeness of the different variants, vaccines and preventive measures, EuCARE has secured the appropriate cohorts from diverse geographic areas including European countries, Kenya, Mexico, Russia and Vietnam, and will consolidate or expand interactions with other cohorts. To deal with complex interactions among many variables, including large dimensional parameters, EuCARE harnesses the power of artificial intelligence to define the role of viral variants and inform clinical guidelines and prevention measures.In the longer-term, EuCARE is committed to maintain active cooperation beyond the duration of the project with a dedicated task in the project. The solid IT and ethics infrastructure and the harmonised research procedures will make the cohort and laboratory network rapidly available to tackle newly emerging infectious diseases, thus contributing to pandemic preparedness on a global scale.
Consortium (20)
🇮🇹 EURESIST NETWORK GEIEIT
coordinator🇮🇹 AZIENDA SOCIO-SANITARIA TERRITORIALE (ASST) SANTI PAOLO E CARLOIT
partner🇩🇪 EBERHARD KARLS UNIVERSITAET TUEBINGENDE
partner🇩🇪 HEINRICH-HEINE-UNIVERSITAET DUESSELDORFDE
partner🇮🇱 IBM ISRAEL - SCIENCE AND TECHNOLOGY LTDIL
partner🇬🇧 IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINEGB
partner🇬🇪 INFECTIOUS DISEASES, AIDS AND CLINICAL IMMUNOLOGY RESEARCH CENTERGE
partner🇮🇹 ISTITUTO EUROPEO DI ONCOLOGIA SRLIT
partner🇮🇹 ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICOIT
partner🇸🇪 KAROLINSKA INSTITUTETSE
partner🇩🇪 KLINIKUM DER UNIVERSITAET ZU KOELNDE
partner🇧🇪 ORGANIZING BUREAU OF EUROPEAN SCHOOL STUDENT UNIONSBE
partner🇵🇱 POMORSKI UNIWERSYTET MEDYCZNY W SZCZECINIEPL
partner🇵🇹 UNIDADE LOCAL DE SAUDE LISBOA OCIDENTAL EPEPT
partner🇵🇹 UNIVERSIDADE NOVA DE LISBOAPT
partner🇮🇹 UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATAIT
partner🇮🇹 UNIVERSITA DEGLI STUDI DI SIENAIT
partner🇮🇹 UNIVERSITA DEL SALENTOIT
partner🇬🇧 UNIVERSITY COLLEGE LONDONGB
partner🇱🇹 VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOSLT
partnerProject Results (75)
Source: CORDIS, the EU research results database.
▶Publications (67)
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status
Greta Marchegiani, Luca Carioti, Luigi Coppola, Marco Iannetta, Leonardo Alborghetti, Vincenzo Malagnino, Livia Benedetti, Maria Mercedes Santoro, Massimo Andreoni, Loredana Sarmati, Claudia Alteri, Francesca Ceccherini-Silberstein, Maria Concetta Bellocchi
An informed deep learning model of the Omicron wave and the impact of vaccination
Elham Shamsara, Florian König, Nico Pfeifer
Bacterial and viral co-infections in adult patients hospitalized with COVID-19 throughout the pandemic: A Multinational Cohort Study in the EuCARE Project
Pontus Hedberg, Karol Serwin, Maria Francesca Greco, Joana P V Pereira, Dovile Juozapaite, Sara De Benedittis, Francesca Bai, Nadine Lübke, Tobias Wienemann, Iuri Fanti, Florian König, Nico Pfeifer, Rolf Kaiser, Maurizio Zazzi, Alessandro Cozzi-Lepri, Daniel Naumovas, Giulia Marchetti, Milosz Parczewski, Björn-Erik Ole Jensen, Francesca Incardona, Anders Sönnerborg, Pontus Nauclér
Comparable gut mucosal breakdown and microbial translocation in severe COVID-19 with and without HIV infection
Sabrina Marozin, Valeria Bono, Martina Mazzoccoli, Matteo Augello, Roberta Rovito, Lucia Taramasso, Antonio Di Biagio, Annapaola Callegaro, Franco Maggiolo, Elisa Borghi, Camilla Tincati, Giulia March
Comparative Analysis of Early COVID‐19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials
Valentina Mazzotta, Alessandro Cozzi Lepri, Cosmo Del Borgo, Simone Lanini, Silvia Meschi, Silvia Garattini, Silvia Rosati, Valentina Siciliano, Alessandra Vergori, Luigi Coppola, Antonio Falletta, An
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease
Ilaria Mastrorosa, Alessandro Cozzi-Lepri, Giulia Matusali, Francesca Colavita, Simone Lanini, Martina Rueca, Alessandra Oliva, Giulia Berno, Alessandra Vergori, Silvia Rosati, Jessica Paulicelli, Enr
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome
Giulia Del Duca, Isabella Sperduti, Alessandro Cozzi Lepri, Valentina Mazzotta, Francis Drobniewski, Roberta Gagliardini, Marisa Fusto, Maria Maddalena Plazzi, Jessica Paulicelli, Alessandra Vergori,
Determinants of post COVID-19 clinic attendance among SARS-CoV-2-infected individuals in Stockholm, Sweden: a population-based cohort study
Pontus Hedberg, Peder af Geijerstam, John Karlsson Valik, Christer Almgren-Lidman, Anders Ternhag, Pontus Naucler
Determinants of vaccine hesitancy among healthcare workers in an international multicenter study within the EuCARE project
Francis Drobniewski, Marcia Ashmi, Dian Kusuma, Raheelah Ahmad, Daniel Naumovas, Dovilė Juozapaitė, Cristina Toscano, Elvira Perea, Ana B. Abecasis, Miguel Viveiros, Joana P. V. Pereira, Björn-Erik
Factors influencing vaccine hesitancy among United Kingdom adolescents in a senior high school environment and actions to address it
Francis Drobniewski, Marcia Ashmi, Raheelah Ahmad, Changchunzi He, Marianna Bogdanova, Alan Garbacz, Ahmed Moustafa
Incidence, risk factors and outcomes of healthcare-associated bacterial infections in COVID-19 patients receiving respiratory support: a retrospective cohort study
Matteo Augello, Roberto Castoldi, Alessandro Tavelli, Riccardo Nardo, Valentina Sala, Lorenzo Albertini, Lorenzo Brando Lundgren, Sara De Benedittis, Elisa Borghi, Ottavia Viganò, Giulia Marchetti
Investigating the Interplay of SARS-CoV-2 RNAemia and Peripheral Inflammation in Platelet Dysfunction During Acute SARS-CoV-2 Infection
Mariangela Scavone, Roberta Rovito, Claudia Ghali, Antonella Fioretti, Bianca Clerici, Elena Bossi, Camilla Tincati, Andrea Santoro, Elisa Borghi, Gianmarco Podda, Giulia Marchetti
Long-term healthcare use of COVID-19 cases in 2020: a two-year follow-up in Stockholm, Sweden
Nicholas Baltzer, Pontus Hedberg, Sara Nordqvist Kleppe, Joakim Dillner, Anders Sönnerborg, Jan Albert, Kristoffer Strålin, Pär Sparén, Pontus Nauclér
Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV
Matteo Augello; Valeria Bono; Roberta Rovito; Alessandro Tavelli; Andrea Santoro; Camilla Tincati; Alessandra Vergori; Anna Maria Azzini; Elda Righi; Gianluca Spiteri; Stefano Porru; Silvia Meschi; Stefania Notari; Fabrizio Maggi; Andrea Antinori; Evelina Tacconelli; Antonella d’Arminio Monforte; Giulia Marchetti; on behalf of the VaxICONA-ORCHESTRA Study Group
Markers of T-cell dysfunction and not inflammaging predict the waning of humoral responses to SARS-CoV-2 mRNA booster vaccination in people with HIV
Matteo Augello, Valeria Bono, Roberta Rovito, Andrea Santoro, Camilla Tincati, Giulia Marchetti
Multi-layered deep immune profiling, SARS-CoV-2 RNAemia and inflammation in unvaccinated COVID-19 individuals with persistent symptoms
Roberta Rovito, Valeria Bono, Nicolò Coianiz, Valentina Cazzetta, Sara Franzese, Joanna Mikulak, Clara Di Vito, Francesca Bai, Guillaume Beaudoin-Bussières, Alexandra Tauzin, Matteo Augello, Camilla Tincati, Andrea Santoro, Elisa Borghi, Sabrina Marozin, Andrés Finzi, Silvia della Bella, Domenico Mavilio, Giulia Marchetti, null null
Short and long-term trajectories of the post COVID-19 condition: Results from the EuCARE POSTCOVID study
Andrea Santoro, Francesca Bai, Maria Francesca Greco, Roberta Rovito, Matteo Sala, Lidia Borghi, Kyrie Piscopo, Elena Vegni, Julia Fonseca de Morais Caporali, Carolina Coimbra Marinho, Arnaldo Santos Leite, Maria Mercedes Santoro, Francesca Ceccherini Silberstein, Marco Iannetta, Dovile Juozapaite, Edita Strumiliene, André Almeida, Cristina Toscano, Jesus Arturo Ruiz Quinones, Luca Carioti, Chiara Mommo, Iuri Fanti, Francesca Incardona, Giulia Marchetti, null null
The Effect of COVID-19 Vaccination on the Risk of Persistent Post–COVID-19 Condition: Cohort Study
Pontus Hedberg, Suzanne Desirée van der Werff, Pontus Nauclér
The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial
John Karlsson Valik, Pontus Hedberg, Piotr Nowak, Ola Blennow, Robert Dyrdak, Jan Vesterbacka, Johan Zetterqvist, Pontus Naucler
Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir
Bai, Francesca; Beringheli, Tomaso; Vitaletti, Virginia; Santoro, Andrea; Molà, Francesco; Copes, Alessandro; Gemignani, Nicole; Pettenuzzo, Sofia; Castoldi, Roberto; Varisco, Benedetta; Nardo, Riccardo; Lundgren, Lorenzo Brando; Ligresti, Riccardo; Sala, Matteo; Albertini, Lorenzo; Augello, Matteo; Biasioli, Lorenzo; Bono, Valeria; Rovito, Roberta; Bini, Teresa; Passarella, Sabrina; Orfeo, Nicola Vincenzo; Monforte, Antonella d'Arminio; Marchetti, Giulia
Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients
Gabriella Rondanina, Tania Buttiron Webber, Oriana D’Ecclesiis, Marco Musso, Irene Maria Briata, Nicoletta Provinciali, Monica Boitano, Matteo Clavarezza, Mauro D’Amico, Carlotta Defferrari, Alberto Gozza, Leonello Innocenti, Alessio Carbone, Martino Oliva, Emanuela Marcenaro, Francesca Filauro, Sara Gandini, Andrea DeCensi
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Fiaschi L, Biba C, Varasi I, Bartolini N, Paletti C, Giammarino F, Saladini F, Zazzi M, Vicenti I.
In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project
Hedberg P, Parczewski M, Serwin K, Marchetti G, Bai F, Jensen BEO, Pereira JPV, Drobniewski F, Reschreiter H, Naumovas D, Ceccherini-Silberstein F, Rubio Quintanares GH, Mwau M, Toscano C, König F, Pfeifer N, Zazzi M, Fanti I, Incardona F, Cozzi-Lepri A,
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant
Müller TR, Gao Y, Wu J, Ribeiro O, Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, Vesterbacka J, Akber M, Söderdahl G, Smith CIE, Loré K, Chen MS, Ljungman P, Ingelman-Sundberg HM, Ljunggren HG, Österborg A, Sette A, Grifoni A, Aleman S, Bugg
Oro-faecal transmission of SARS-CoV-2: A systematic review of studies employing viral culture from gastrointestinal and other potential oro-faecal sources and evidence for transmission to humans
Sara Gandini, John Conly, Elizabeth A. Spencer, David Evans, Elena C Rosca, Jon Brassey, Susanna Maltoni, Igho Onakpoya, Annette Plüddemann, Tom Jefferson, Carl Heneghan
Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study
Hedberg P, Karlsson Valik J, Abdel Halim L, Alfvén T, Naucler P.
Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and RSV
Hedberg P, Valik JK, Halim LA, Alfvén T, Naucler P.
SARS-CoV-2 mRNA vaccination and short-term changes in viral load and CD4/CD8 T-cell counts in people living with HIV
Alessandra Vergori, Alessandro Cozzi-Lepri, Alessandro Tavelli, Valentina Mazzotta, Anna Maria Azzini, Roberta Gagliardini, Ilaria Mastrorosa, Alessandra Latini, Giovanni Pellicanò, Lucia Taramasso, Francesca Ceccherini-Silberstein, Maddalena Giannella, Evelina Tacconelli, Giulia Marchetti, Antonella d'Arminio Monforte, Andrea Antinori
SARS-CoV-2 Test-to-Stay in Daycare
Felix Dewald, Gertrud Steger, Irina Fish, Ivonne Torre-Lage, Christina Hellriegel, Esther Milz, Anja Kolb-Bastigkeit, Eva Heger, Mira Fries, Michael Buess, Niklas Marizy, Barbara Michaelis, Isabelle Suárez, Gibran Horemheb Rubio Quintanares, Martin Pirkl, Annette Aigner, Max Oberste, Martin Hellmich, Anabelle Wong, Juan Camilo Orduz, Gerd Fätkenheuer, Jörg Dötsch, Annelene Kossow, Eva-Maria Moench, Gustav Quade, Udo Neumann, Rolf Kaiser, Madlen Schranz, Florian Klein
Serological screening in a large-scale municipal survey in Cascais, Portugal, during the first waves of the COVID-19 pandemic: lessons for future pandemic preparedness efforts
Seabra S, Merca F, Pereira B, Fonseca I, Carvalho AC, Brito V, Alves D, Libin P, Martins MRO, Miranda MN, Pingarilho M, Pimentel V, Abecasis AB
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study
Francesca Bai, Andrea Santoro, Pontus Hedberg, Alessandro Tavelli, Sara De Benedittis, Júlia Fonseca de Morais Caporali, Carolina Coimbra Marinho, Arnaldo Santos Leite, Maria Mercedes Santoro, Francesca Ceccherini Silberstein, Marco Iannetta, Dovilé Juozapaité, Edita Strumiliene, André Almeida, Cristina Toscano, Jesús Arturo Ruiz-Quiñones, Chiara Mommo, Iuri Fanti, Francesca Incardona, Alessandro Cozzi-Lepri, Giulia Marchetti
Artificial neural network based prediction of the lung tissue involvement as an independent in-hospital mortality and mechanical ventilation risk factor in COVID-19
Parczewski M, Kufel J, Aksak-Wąs B, Piwnik J, Chober D, Puzio T, Lesiewska L, Białkowski S, Rafalska-Kosior M, Wydra J, Awgul K, Grobelna M, Majchrzak A, Dunikowski K, Jurczyk K, Podyma M, Serwin K, Musiałek J
Clinical outcomes during and beyond different COVID-19 critical illness variant periods compared with other lower respiratory tract infections
Pontus Hedberg; Nicholas Baltzer; Fredrik Granath; Michael Fored; Johan Mårtensson; Pontus Nauclér
Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network)
Barbara Rossetti; Francesca Incardona; Giulia Di Teodoro; Chiara Mommo; Francesco Saladini; Rolf Kaiser; Anders Sönnerborg; Thomas Lengauer; Maurizio Zazzi
Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review.
Rosca, E.C.; Heneghan, C.; Spencer, E.A.; Plüddemann, A.; Maltoni, S.; Gandini, S.; Onakpoya, I.J.; Evans, D.; Conly, J.M.; Jefferson, T.
EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project
Hedberg P, Varisco B, Bai F, Sönnerborg A, Naucler P, Pfeifer N, Cozzi-Lepri A, Ceccherini-Silberstein F, Naumovas D, Drobniewski F, Jensen BO, Toscano C, Parczewski M, Quintanares GHR, Mwau M, Pinto JA, Incardona F, Mommo C, Marchetti G.
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations
Varisco B, Bai F, De Benedittis S, Tavelli A, Cozzi-Lepri A, Sala M, Miraglia FG, Santoro MM, Ceccherini-Silberstein F, Shimoni Y, Ravid S, Kozlovski T, König F, Pfeifer N, Shamsara E, Parczewski M, Monforte AD, Incardona F, Mommo C, Marchetti G.
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
Raimondi S, Gandini S, Rubio Quintanares GH, Abecasis A, Lopalco PL, D'Ecclesiis O, Chiocca S, Tomezzoli E, Cutica I, Mazzoni D, Amparo N, Pingarilho M, Carmagnola D, Dallavia C, Zuccotti G, Ronchini C, Bellerba F, Dewald F, Kaiser R, Incardona F; Eucare
Frequency of Atypical Mutations in the Spike Glycoprotein in SARS-CoV-2 Circulating from July 2020 to July 2022 in Central Italy: A Refined Analysis by Next Generation Sequencing
Bellocchi MC, Scutari R, Carioti L, Iannetta M, Marchegiani G, Piermatteo L, Coppola L, Tedde S, Duca L, Malagnino V, Ansaldo L, Braccialarghe N, D Anna S, Santoro MM, Di Lorenzo A, Salpini R, Teti E, Svicher V, Andreoni M, Sarmati L, Ceccherini-Silberste
Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study
Kevličius L, Šablauskas K, Maneikis K, Juozapaitė D, Ringelevičiūtė U, Vaitekėnaitė V, Davainienė B, Daukėlaitė G, Vasilevska D, Stoškus M, Narkevičiūtė I, Sivickienė V, Rudaitis K, Minkauskas M, Naumovas D, Beinortas T, Griškevičius L
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
Ray S, Narayanan A, Vesterbacka J, Blennow O, Chen P, Gao Y, Gabarrini G, Ljunggren H-G, Buggert M, Manoharan L, Sällberg Chen M, Aleman S, Sönnerborg A & Nowak P
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV
Vergori, A.; Cozzi-Lepri, A.; Matusali, G.; Cicalini, S.; Bordoni, V.; Meschi, S.; Mazzotta, V.; Colavita, F.; Fusto, M.; Cimini, E.; et al.
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination
Varasi I, Lai A, Fiaschi L, Bergna A, Gatti A, Caimi B, Biba C, Della Ventura C, Balotta C, Riva A, Zehender G, Zazzi M, Vicenti I.
Outcomes of Pediatric SARS-CoV-2 Omicron Infection vs Influenza and Respiratory Syncytial Virus Infections
Hedberg P, Abdel-Halim L, Valik JK, Alfvén T, Nauclér P.
Post–COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden
Hedberg P, Nauclér P
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
Vicenti I, Basso M, Pirola N, Bragato B, Rossi MC, Giobbia M, Pascoli S, Vinci A, Caputo S, Varasi I, Biba C, Fiaschi L, Zazzi M, Parisi SG.
SARS-CoV-2 trends in Italy, Germany and Portugal and school opening during the period of Omicron variant dominance: A quasi experimental study in the EuCARE project
Bellerba F, Bardeck N, Boehm M, D'Ecclesiis O, Raimondi S, Tomezzoli E, Miranda MS, Martins Alves I, Alves D, Abecasis A, Gabellone V, Gabrielli E, Vaglio G, Shamsara E, Pfeifer N, Mommo C, Incardona, Kaiser R, Gandini S
Sociodemographic disparities affect COVID-19 vaccine uptake in non-elderly adults with increased risk of severe COVID-19
Hedberg P, Sotoodeh A, Askling HH, Nauclér P.
Sports activity limitation during the COVID-19 pandemic in young Italian athletes: impact on mental health in children, adolescents, and young adults
Tomezzoli E, D'Ecclesiis O, Raimondi S, Pravettoni G, Cammarata G, Testa G, Bellerba F, Gnagnarella P, Iannuzzo ML, Sartorio A, Sasso C, Ricci D, Marazzi N, Galli F, Gandini S
A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2.
Miranda MNS, Pingarilho M, Pimentel V, Torneri A, Seabra SG, Libin PJK, Abecasis AB.
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
Vicenti I, Basso M, Dragoni F, Gatti F, Scaggiante R, Fiaschi L, Parisi SG, Zazzi M.
COVID-19 Vaccine Hesitancy in Diverse Groups in the UK-Is the Driver Economic or Cultural in Student Populations.
Drobniewski F, Kusuma D, Broda A, Castro-Sánchez E, Ahmad R.
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
Fiaschi L, Dragoni F, Schiaroli E, Bergna A, Rossetti B, Giammarino F, Biba C, Gidari A, Lai A, Nencioni C, Francisci D, Zazzi M, Vicenti I.
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April-December 2021 in Italy
Lai A, Bergna A, Della Ventura C, Menzo S, Bruzzone B, Sagradi F, Ceccherini-Silberstein F, Weisz A, Clementi N, Brindicci G, Vicenti I, Sasset L, Caucci S, Corvaro B, Ippoliti S, Acciarri C, De Pace V, Lanfranchi L, Bellocchi MC, Giurato G et al.
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy.
Meschiari M, Cozzi-Lepri A, Tonelli R, Bacca E, Menozzi M, Franceschini E, Cuomo G, Bedini A, Volpi S, Milic J, Brugioni L, Romagnoli E, Pietrangelo A, Corradini E, Coloretti I, Biagioni E, Busani S, Girardis M, Cossarizza A, Clini E, Guaraldi G, Mussini
First Case of a COVID-19 Patient Infected by Delta AY.4 with a Rare Deletion Leading to a N Gene Target Failure by a Specific Real Time PCR Assay: Novel Omicron VOC Might Be Doing Similar Scenario?
Alkhatib M, Bellocchi MC, Marchegiani G, Grelli S, Micheli V, Stella D, Zerillo B, Carioti L, Svicher V, Rogliani P, Ceccherini-Silberstein F.
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Co
Antinori A, Cicalini S, Meschi S, Bordoni V, Lorenzini P, Vergori A, Lanini S, De Pascale L, Matusali G, Mariotti D, Cozzi Lepri A, Gallì P, Pinnetti C, Gagliardini R, Mazzotta V, Mastrorosa I, Grisetti S, Colavita F, Cimini E, Grilli E, Bellagamba R, Lap
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies.
Dragoni F, Schiaroli E, Micheli V, Fiaschi L, Lai A, Zehender G, Rossetti B, Gismondo MR, Francisci D, Zazzi M, Vicenti I.
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
Parisi, S.G.; Mengoli, C.; Basso, M.; Vicenti, I.; Gatti, F.; Scaggiante, R.; Fiaschi, L.; Giammarino, F.; Iannetta, M.; Malagnino, V.; Zago, D.; Dragoni, F.; Zazzi, M.
Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients.
Gliga S, Luebke N, Killer A, Gruell H, Walker A, Dilthey AT, Lohr C, Flaßhove C, Orth HM, Feldt T, Bode JG, Klein F, Timm J, Luedde T, Jensen BO.
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19
d'Arminio Monforte A, Tavelli A, De Benedittis S, Bai F, Tincati C, Gazzola L, Viganò O, Allegrini M, Mondatore D, Tesoro D, Barbanotti D, Mulé G, Castoldi R, De Bona A, Bini T, Chiumello D, Centanni S, Passarella S, Orfeo N, Marchetti G, Cozzi-Lepri A, F
SARS-CoV-2 Circulation in the School Setting: A Systematic Review and Meta-Analysis.
Caini S, Martinoli C, La Vecchia C, Raimondi S, Bellerba F, D'Ecclesiis O, Sasso C, Basso A, Cammarata G, Gandini S.
SARS-CoV-2 Mutations and Variants May Muddle the Sensitivity of COVID-19 Diagnostic Assays
Alkhatib M, Carioti L, D'Anna S, Ceccherini-Silberstein F, Svicher V, Salpini R.
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis
Mastrorosa I, Cozzi-Lepri A, Colavita F, Lalle E, Mazzotta V, Cimaglia C, Paulicelli J, Matusali G, Fabeni L, Carletti F, Rosati S, Vita S, Giannico G, Piselli P, Biliotti E, Moghazi SA, Mosti S, Girardi E, Nicastri E, Garbuglia AR, Maggi F, Vaia F, Antin
The Impact of Sport Activity Shut down during the COVID-19 Pandemic on Children, Adolescents, and Young Adults: Was It Worthwhile?
Raimondi S, Cammarata G, Testa G, Bellerba F, Galli F, Gnagnarella P, Iannuzzo ML, Ricci D, Sartorio A, Sasso C, Pravettoni G, Gandini S.
Two-Period Study Results from a Large Italian Hospital Laboratory Attesting SARS-CoV-2 Variant PCR Assay Evolution
Liotti FM, De Maio F, Ippoliti C, Santarelli G, Monzo FR, Sali M, Santangelo R, Ceccherini-Silberstein F, Sanguinetti M, Posteraro B.
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
Alkhatib M, Salpini R, Carioti L, Ambrosio FA, D'Anna S, Duca L, Costa G, Bellocchi MC, Piermatteo L, Artese A, Santoro MM, Alcaro S, Svicher V, Ceccherini-Silberstein F.
▶Deliverables (8)
Documents, reports
Documents, reports
Documents, reports
Other
Documents, reports
Documents, reports
Documents, reports